908 organization(s) found
Pheon Therapeutics
Pheon Therapeutics is leveraging two decades of ADC experience to build a novel pipeline of next generation ADCs which offer the potential to treat difficult-to-treat solid tumors.
Phillips Healthcare
At Philips, our purpose is to improve people’s health and well-being through meaningful innovation. We aim to improve 2.5 billion lives per year by 2030, including 400 million in underserved communities. As a technology company, we – and our brand licensees – innovate for people with one consistent belief: there’s always a way to make life better.
Pierre Fabre
We take care of life by designing and developing innovative solutions inspired by consumers and patients and contributing to the well-being of everyone from health to beauty. We achieve this by cooperating with health-care professionals, our trusted partners worldwide, by drawing relentless inspiration from nature and plants, and by placing pharmaceutical ethics at the very heart of our operations.
PinkDrive – South Africa
Organisation focusing on cancer (especially women’s cancers) awareness, screening and early detection campaigns in South Africa. (From list of cancer NGOs in South Africa.)(canceralliance.org.za)
Pinot Bio
Pinotbio is a biotech company developing new treatments for patients resistant to existing therapies based on innovative new drug modalities such as antibody-drug conjugates (ADCs). Based on our strong R&D capabilities, we have built our next-generation ADC platform, PINOT-ADC� independently and have been working with various partners to research new ADC anticancer treatments.
PMV Pharmaceuticals
At PMV, we believe that by specifically targeting each mutant p53 we can fundamentally disrupt the course of cancer. Our research and development efforts are dedicated to selectively targeting mutant p53, providing unique therapies for any patient whose tumor harbors these gene mutations.
Prague Metabolism Symposium
The group that organizes the Prague Metabolism and Signaling Symposium
Predicta Biosciences
Advanced biopsy and reporting technology: Our approach delivers unprecedented sensitivity, accuracy, and informativity for diagnostics of multiple myeloma and other plasma cell dyscrasias. Our platform leverages whole genome sequencing (WGS) of cells isolated from both bone marrow and blood, providing significantly enhanced sensitivity and a wealth of diagnostic information compared to traditional bone marrow FISH assays. This enables more accurate diagnoses and earlier disease intervention.
Princess Máxima Center
The Princess Máxima Center is not an ordinary hospital, but a research hospital. All children with cancer in the Netherlands are treated here. This makes the Princess Máxima Center the largest pediatric cancer center in Europe. Over 600 researchers and 900 healthcare professionals work closely with Dutch and international hospitals on better treatments and new perspectives on cures. In this way, we give the child of today the very best care and take important steps to improve the chances of survival for the children who are not yet cured.
Priothera
Extending and enhancing the quality of life and radically transforming the treatment of patients with hematological malignancies
ProEn Therapeutics
ProEn Therapeutics Inc. is a new drug development company that focuses on oncology, and that contributes to the healthy life of mankind through biopharmaceuticals developed for protein engineering.
Project Pink Blue – Nigera
Nonprofit engaged in raising cancer awareness, patient navigation, advocacy and free breast and cervical cancer screening; launched Nigeria’s first patient-navigation service and toll-free cancer hotline.
Providence Therapeutics
Providence Therapeutics is an mRNA medicines company developing transformative cancer immunotherapies and protection from hard-to-treat infectious diseases. Our therapeutics come from a fully integrated, end-to-end Research and Development Ecosystem combining target discovery, our proprietary mRNA platform, INTENT� lipid nanoparticle platform (LNP), and a proven mRNA-LNP manufacturing platform applicable to fully personalized medicine all the way to pandemic scale manufacturing.
PSCC
The Paris Saclay Cancer Cluster (PSCC) is an internationally renowned biocluster to accelerate oncology innovation
Qidong Liver Cancer Institute / Qidong Cancer Registry
Focused on liver-cancer epidemiology and registry; represents regionally oriented cancer surveillance and research outside major megacities. (publications.iarc.who.int)
Qure Biotechnology
QureBio Ltd. was established in July 2017 and aims to develop novel therapeutic drugs for the treatment of tumors, autoimmune diseases and metabolic diseases in China and around the world to benefit patients. The company has multiple technology platforms for antibody drug development including phage display, hybridoma as well as protein and antibody engineering. In addition, the company's goal is to make an effective and robust manufacturing process for biologics.